X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cannabidiol (334) 334
index medicus (330) 330
humans (215) 215
pharmacology & pharmacy (177) 177
cannabinoids (175) 175
marijuana (139) 139
animals (137) 137
male (137) 137
cannabis (136) 136
tetrahydrocannabinol (110) 110
cannabidiol - pharmacology (90) 90
neurosciences (84) 84
delta-9-tetrahydrocannabinol (78) 78
clinical neurology (74) 74
delta-tetrahydrocannabinol (74) 74
pharmacokinetics (72) 72
pharmacology (70) 70
epilepsy (69) 69
female (68) 68
psychiatry (67) 67
adult (61) 61
analysis (59) 59
thc (59) 59
rats (58) 58
cannabidiol - therapeutic use (57) 57
mice (50) 50
cannabidiol - administration & dosage (49) 49
endocannabinoid system (48) 48
medical marijuana (47) 47
dronabinol - pharmacology (46) 46
seizures (45) 45
cannabinoids - pharmacology (42) 42
cannabidiol - pharmacokinetics (40) 40
cannabinoids - therapeutic use (40) 40
double-blind (40) 40
dronabinol - administration & dosage (38) 38
cbd (37) 37
dose-response relationship, drug (37) 37
health aspects (37) 37
in-vitro (37) 37
middle aged (37) 37
adolescent (36) 36
metabolism (36) 36
young adult (36) 36
clinical trials (34) 34
drug interactions (34) 34
schizophrenia (34) 34
care and treatment (33) 33
drug combinations (33) 33
receptor (33) 33
cannabinoid (32) 32
drug therapy (32) 32
article (31) 31
double-blind method (31) 31
dronabinol - analogs & derivatives (31) 31
drugs (31) 31
multiple-sclerosis (31) 31
multiple sclerosis (30) 30
neurology (30) 30
pain (30) 30
research (29) 29
anticonvulsants - therapeutic use (28) 28
anxiety (28) 28
metabolites (28) 28
dronabinol - pharmacokinetics (27) 27
mental disorders (26) 26
receptors (26) 26
spasticity (26) 26
administration, oral (25) 25
dosage and administration (25) 25
drug abuse (25) 25
cannabidiol - blood (24) 24
cannabidiol - metabolism (24) 24
cannabis - chemistry (24) 24
smoking (24) 24
studies (24) 24
treatment outcome (24) 24
dronabinol - blood (23) 23
kinetics (23) 23
mass spectrometry (23) 23
phenols (23) 23
biochemistry & molecular biology (22) 22
biomedicine (22) 22
cannabidiol - adverse effects (22) 22
digestive system diseases (22) 22
epilepsy - drug therapy (22) 22
identification (22) 22
review (22) 22
symptoms (22) 22
usage (22) 22
cannabinoids - metabolism (21) 21
cannabinoids - pharmacokinetics (21) 21
dronabinol (21) 21
dronabinol - therapeutic use (21) 21
pharmacology/toxicology (21) 21
plant cannabinoids (21) 21
time factors (21) 21
brain (20) 20
cannabidiol - chemistry (20) 20
disease models, animal (20) 20
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 11/2017, Volume 109, pp. 21 - 30
The lipophilic phytocannabinoids cannabidiol (CBD) and Δ -tetrahydrocannabinol (THC) show therapeutic efficacy in various medical conditions. Both molecules... 
Cannabinoids | Oral bioavailability | Piperine | SNEDDS | First pass effect | RESVERATROL | CURCUMIN | P-GLYCOPROTEIN | UDP-GLUCURONOSYLTRANSFERASE | IN-VITRO | LIPID-BASED FORMULATIONS | METABOLISM | PHARMACOKINETICS | ENZYMES | PHARMACOLOGY & PHARMACY | Polyunsaturated Alkamides - chemistry | Emulsions | Stilbenes - administration & dosage | Cannabidiol - administration & dosage | Excipients - pharmacokinetics | Nanoparticles - chemistry | Rats, Wistar | Alkaloids - pharmacokinetics | Curcumin - chemistry | Biological Availability | Male | Stilbenes - chemistry | Benzodioxoles - administration & dosage | Curcumin - administration & dosage | Drug Delivery Systems | Lipids - chemistry | Excipients - chemistry | Benzodioxoles - pharmacokinetics | Piperidines - pharmacokinetics | Benzodioxoles - chemistry | Cannabidiol - pharmacokinetics | Cannabidiol - chemistry | Piperidines - administration & dosage | Piperidines - chemistry | Gastrointestinal Absorption | Administration, Oral | Curcumin - pharmacokinetics | Lipids - administration & dosage | Dronabinol - pharmacokinetics | Excipients - administration & dosage | Polyunsaturated Alkamides - administration & dosage | Animals | Lipids - pharmacokinetics | Stilbenes - pharmacokinetics | Alkaloids - administration & dosage | Nanoparticles - administration & dosage | Polyunsaturated Alkamides - pharmacokinetics | Dronabinol - administration & dosage | Dronabinol - chemistry | Alkaloids - chemistry | Index Medicus
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 05/2018, Volume 57, Issue 5, pp. 539 - 545
Endocannabinoid pharmacology is now relatively well understood with a number of endocannabinoids and endogenous cannabinoid neurotransmitters identified and... 
PHARMACOLOGY & PHARMACY | CANNABIDIOL | DELTA-9-TETRAHYDROCANNABINOL | THC | Appetite | Neurotransmitters | Pain | Medical marijuana | Disease | Quality control | Systematic review | Physiology | Pharmacology | Regulation | Drug dosages | Pharmaceuticals
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 11/2018, Volume 9, pp. 1365 - 1365
Journal Article
Epilepsia, ISSN 0013-9580, 08/2019, Volume 60, Issue 8, pp. 1586 - 1592
Objective To evaluate the pharmacokinetics of a purified oral cannabidiol (CBD) capsule administered with and without food in adults with refractory epilepsy.... 
cannabidiol | epilepsy | food‐effect | pharmacokinetics | CBD | SINGLE | METABOLISM | food-effect | MECHANISMS | SMOKING | ABSORPTION | PHASE-I | CLINICAL NEUROLOGY | Medical research | Medical examination | Epilepsy | Medicine, Experimental | Marijuana | Adults | Blood | Convulsions & seizures | Cannabis | Fasting | Bioavailability | Localization | Pharmacokinetics | Seizures | Index Medicus
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 08/2019, Volume 59, Issue 8, pp. 1110 - 1119
The pharmacokinetics and safety of a single oral dose of 200‐mg plant‐derived pharmaceutical formulation of highly purified cannabidiol (CBD) in oral solution... 
cannabidiol | hepatic impairment | pharmacokinetic | cannabinoid | liver function | SEIZURES | METABOLISM | PHARMACOLOGY & PHARMACY | Plasma | Infinity | Liver | Impairment | Mass spectroscopy | Liquid chromatography | Exposure | Pharmacology | Confidence intervals | Metabolites | Titration | Safety | Pharmacokinetics | Mass spectrometry | Editor's Choice | Special Populations
Journal Article
PSYCHOPHARMACOLOGY, ISSN 0033-3158, 11/2011, Volume 218, Issue 2, pp. 443 - 457
Rationale The interactions between Delta(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) during chronic treatment, and at equivalent doses, are not well... 
MOUSE-BRAIN | 5-HT1A RECEPTORS | PSYCHIATRY | HIGH-POTENCY | Cannabidiol | ELEVATED PLUS-MAZE | NEUROSCIENCES | THC | BED NUCLEUS | Cannabis | CB1 | STRIA TERMINALIS | RECEPTOR-DEPENDENT MECHANISM | Adolescent | PHARMACOLOGY & PHARMACY | Anxiety | MICE | Reward | Pharmacokinetics | CANNABINOIDS
Journal Article
Canadian Journal of Veterinary Research, ISSN 0830-9000, 07/2018, Volume 82, Issue 3, pp. 178 - 183
The purpose of this study was to determine the pharmacokinetics of cannabidiol (CBD) in healthy dogs. Thirty, healthy research dogs were assigned to receive 1... 
VETERINARY SCIENCES | MARIJUANA | CANNABINOIDS | Cannabidiol - administration & dosage | Oils | Administration, Oral | Area Under Curve | Half-Life | Dogs - metabolism | Male | Dogs - blood | Administration, Cutaneous | Skin Cream | Dose-Response Relationship, Drug | Animals | Cannabidiol - blood | Cannabidiol - pharmacokinetics
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 11/2019, Volume 158, pp. 107733 - 107733
Cannabidiol and cannabidiol-enriched products have recently attracted much attention as an add-on therapy for epilepsy, especially drug-resistant seizures. It... 
Cannabidiol | Drug-drug interactions | Antiepileptic drugs | Seizures | Index Medicus
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 09/2018, Volume 7, Issue 7, pp. 751 - 758
Cannabidiol (CBD) is the main nonpsychoactive component of the cannabis plant. It has been associated with antiseizure, antioxidant, neuroprotective,... 
cannabidiol | pharmacokinetics | cannabinoids | oral drug delivery | MEDICAL CANNABIS | SAFETY | HUMANS | SPASTICITY | TRIAL | MULTIPLE-SCLEROSIS | TREATMENT-RESISTANT EPILEPSY | DELTA-TETRAHYDROCANNABINOL | PHARMACOLOGY & PHARMACY | THC/CBD OROMUCOSAL SPRAY | PHASE-I | Pharmacology | Bioavailability
Journal Article